Expression of Toll-like receptors 2 and 4 is downregulated after operation
Surgery 135(4): 376-385
Article 2004 English
Authors
HI
Hirofumi Ikushima
TN
Toshirou Nishida
KT
Kiyoshi Takeda
Abstract
1 min read
Background
Toll-like receptors (TLR) that recognize microbial pathogens play a critical role in innate immunity; however, their expression and function after surgery remain unknown. The aim of this study was to examine TLR2 and TLR4 expression on monocytes and their responses to each agonist after surgical insults.
Methods
Blood samples were obtained from 83 patients who underwent gastrointestinal surgery. TLR2, TLR4, and inducible nitric oxide synthase expressions on peripheral blood mononuclear cells (PBMCs) were analyzed by flow cytometry. Macrophage-activating lipopeptide-2 or lipopolysaccharide-induced tumor necrosis factor–α and interleukin-6 production was measured by enzyme-linked immunosorbent assay.
Results
TLR2 and TLR4 decreased and showed the lowest values on the postoperative days 3 and 1, respectively. Macrophage-activating lipopeptide-2–stimulated tumor necrosis factor–α and interleukin-6 production was decreased immediately after the operation (P<.05), increased to a maximum value on postoperative day 1, and then decreased gradually. Lipopolysaccharide-stimulated tumor necrosis factor–α production was also suppressed immediately (P<.05) after operation then showed a gradual increase to maximum values on postoperative day 3. Inducible nitric oxide synthase in cultured PBMC that was obtained immediately after operation was upregulated (P<.05).
Conclusion
Expressions of TLR2 and TLR4 were downregulated by operation, and agonist-induced cytokine production was suppressed transiently and soon increased through the activation of PBMC. The present study may offer new insights for postoperative modulation of innate immunity under surgical stress.
Trude H. Flo, Liv Ryan, Eicke Latz, Osamu Takeuchi, Brian G. Monks, Egil Lien, Øyvind Halaas, Akira Shizuo, Gudmund Skjåk‐Bræk, Douglas T. Golenbock, Terje Espevik
Discussion(0)
No comments yet. Be the first to comment.